← SynDRA
SR-31747 free base
SynDRA canonical compound SYN2054256 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SIGMAR1 |
|---|
| Mechanism of action | immunosuppressant |
|---|
| Indication | prostate cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Enzyme Inhibitors
- Immunosuppressive Agents
- immunosuppressant
Cross-references
Synonyms
- UNII-G622F7P8LU
- G622F7P8LU
- RefChem:203116
- SR-31747 (free base)
- C23H34ClN
- orb1691821
- SCHEMBL6652640
- SCHEMBL29629099
- SR-31747 BASE
- BDBM50405515
- HY-13751A
- AKOS015924573
- CS-6770
- DB-356401
- NS00068638
- T38720
- MS-26680
- UNII-9K6U3I1UR0
- T16926
- HY-13751
- RefChem:560136
- SCHEMBL7285292
- ARYLACENAMIDE [WHO-DD]
- CS-0007776
- SR-317417A
- sr31747a
- SR 31747A
- SR31747
- C23H35Cl2N
- MFCD00894102
- SR-31747
- SCHEMBL29360056
- AKOS022180759
- orb1706608
- 9K6U3I1UR0
- SR-31747 HCl
- SR-31747 HYDROCHLORIDE
- Arylacenamide
Look up SR-31747 free base in the interactive SynDRA portal →